Abstracts and Articles

Glecaprevir/Pibrentasvir Versus Sofosbuvir/Velpatasvir for Hepatitis C Virus Genotype 6: A Systematic Review and Meta-Analysis.

Le Duong Hoang Huy (DHH);Nguyen Dinh Chuong (DC);Kanokudom Sitthichai (S);Puenpa Jiratchaya (J);Nilyanimit Pornjarim (P);Tran Anh Ngoc (AN);Honsawek Sittisak (S);Poovorawan Yong (Y)

Causes, associated exposures, and outcomes of cirrhosis and hepatocellular carcinoma in Malawi: an observational cohort and case-control study.

Stockdale Alexander J (AJ);Kreuels Benno (B);Shawa Isaac T (IT);Silungwe Niza M (NM);Mbale Blessings (B);Chetcuti Karen (K);Joekes Elizabeth (E);Mallewa Jane (J);Tannich Egbert (E);Weiler-Normann Christina (C);Lütgehetmann Marc (M);Finch Peter (P);Waddilove Elizabeth (E);Delphin Marion (M);Matthews Philippa C (PC);Thomson Emma C (EC);Geretti Anna Maria (AM);Gordon Melita A (MA)

HBV Dominance Is Associated With a Distinct Inflammatory Milieu in HBV/HCV Coinfection.

Oltmanns Carlos (C);Witte Moana (M);Wranke Anika (A);Deterding Katja (K);Wedemeyer Heiner (H);Falk Christine S (CS);Kraft Anke R M (ARM);Wiegand Steffen B (SB);Cornberg Markus (M)

Impact of Risk Heterogeneity on the Feasibility of Hepatitis C Elimination Among People Who Inject Drugs: A Modelling Study.

Grantz Kyra H (KH);Cummings Derek A T (DAT);Romero Luis Mier-Y-Teran (LM);Astemborski Jacqueline (J);Kirk Gregory D (GD);Thomas David L (DL);Cepeda Javier A (JA);Mehta Shruti H (SH);Wesolowski Amy (A)

Waitlist Mortality in Candidates Listed for Liver Transplant in Females Varies by Liver Disease Aetiology.

Xie Chencheng (C);Elfeki Mohamed (M);Awadalla Mohanad (M);Ismail Abdellatif (A);Arab Juan Pablo (JP);Dunn Winston (W);Younossi Zobair (Z);Wong Robert (R);Singal Ashwani K (AK)

Performance Evaluation of the Elecsys HCV Duo Immunoassay in the Public Healthcare Setting in Cape Town, South Africa.

Hardie Diana R (DR);Korsman Stephen N J (SNJ);Valley-Omar Ziyaad (Z);Petersen Nadia (N);Cable Russell (R);Spearman C Wendy (CW);Sonderup Mark (M)

Small Molecule Targeting of Atypical p38 Protects Against Viral Infection.

Royer Fredejah T (FT);Burton Jeremy C (JC);Burns Johnathan (J);Lloyd Megan G (MG);Onwe Reuben (R);Moffat Jennifer F (JF);Grimsey Neil J (NJ)

Hepatocellular carcinoma risk stratification to identify patients suitable for intensive surveillance in viral hepatitis: the SELECT score.

Kim Yeun-Yoon (YY);Chang Won (W);Lee Jeong Min (JM);Kim Se Woo (SW);Bae Jae Seok (JS);Yoo Jeongin (J);Jeon Sun Kyung (SK);Kim HeeSoo (H);Kim Young Hoon (YH);Choi Jin-Young (JY);Cho Eun Ju (EJ);Lee Yun Bin (YB);Jeong Sook-Hyang (SH);Kim Do Young (DY);Choi Yunhee (Y);Yoon Jeong Hee (JH)

[Recent Advances in the Treatment of Chronic Hepatitis C].

Kim Suk Bae (SB)

Characteristics of an antibody profile associated with protection against hepatitis C virus reinfection in a high-risk cohort.

Chumbe Ana Luz (AL);van den Aardweg Suzanne M D (SMD);Boyd Anders (A);Grobben Marloes (M);Koekkoek Sylvie M (SM);Zon Ian (I);Prins Maria (M);Sliepen Kwinten (K);van Gils Marit J (MJ);Schinkel Janke (J)

Serological and molecular characterization of hepatitis E virus and co-infections during the 2014 Biratnagar outbreak in Nepal.

Gupta Birendra Prasad (BP);Sah Ajay Kumar (AK);Sah Abhay Kumar (AK);Gupta Vivek Prasad (VP);Ghimire Dinesh Prasad (DP);Acharya Nikita (N);Wagle Chandramani (C)

Hepatitis D Virus Positivity among Patients from Liberia with Chronic Hepatitis B Virus Infection.

Akambase Joseph A (JA);Goble Spencer R (SR);Ali Yasmin O (YO);Ali Nahdiya M (NM);Noska Amanda J (AJ);Shaw Chelsea R (CR);Powell Jesse (J)

Efficacy and safety of sofosbuvir-based therapies for treating HCV in children: observations from a real-world setting.

Pokorska-Śpiewak Maria (M);Dobrzeniecka Anna (A);Talarek Ewa (E);Aniszewska Małgorzata (M);Marczyńska Magdalena (M)

2025 KASL clinical practice guidelines for management of hepatitis C.

Jang Eun Sun (ES);Heo Nae Yun (NY);Jeong Jae Yoon (JY);Park Jung Gil (JG);Song Do Seon (DS);Cho Eun Ju (EJ);Lee Chang Hun (CH);Lee Jae Seung (JS);Yoon Jae Hyun (JH);Han Seul Ki (SK);Jung Young Kul (YK); ()

Assessing Deceased Donor Kidneys Through Post-Transplant Survival Prediction Algorithms.

Potluri Vishnu S (VS);Rubin Jeremy (J);Zee Jarcy (J);Ratcliffe Sarah J (SJ);Harhay Michael O (MO);Abt Peter L (PL);Vail Emily A (EA);Parikh Chirag R (CR);Bloom Roy D (RD);Gasparini Alessandro (A);Crowther Michael (M);Goldberg David S (DS);Reese Peter P (PP)

Prediction of Hepatocellular Carcinoma After Direct-Acting Antiviral Therapy Using Agile 3+ and End-of-Treatment Alpha-Fetoprotein Levels in Patients With Hepatitis C.

Kuwano Akifumi (A);Yada Masayoshi (M);Tanaka Kosuke (K);Hamomoto Taikan (T);Kurosaka Kazuki (K);Suzuki Hideo (H);Motomura Kenta (K)

Enhancing Hepatitis B and C Prevention Among People Who Use Drugs: Evaluating an Educational Intervention at a Drop-In Center in Southwest Iran based on Protection Motivation Theory.

Rakhshani Tayebeh (T);Chalesh Siavash (S);Arman Ali (A);Taravatmanesh Samira (S);Jeihooni Ali Khani (AK)

A scoping review of grey zone use for transfusion-transmitted infection screening among blood donors.

Chaurasia Rahul (R);Sil Suhasini (S);Khiamniungan Chanchi (C);Patidar Gopal Kumar (GK);Pandey Hem Chandra (HC)